We have developed a technology that makes it possible to measure vital signs with no physical or optical contact within an estimated distance of up to 7 meters to the target.
founded, trademark registered, hired employees, MVP (chip) is ready & works, PoC is done, medical certification process has started.
B2B - as a reliable and cost-effective replacement for ECG systems
B2B - assisted living for elderly people with the freedom to move without cabling by monitoring 24/7 with our cutting-edge technology, saving time to nurses thanks to fully automatic report system.
B2C - Baby Monitoring system keep track of babies vital signs especially during night, giving the possibility to alarm and prevent SIDS
Problem or Opportunity
babies are under a risk of SIDS (sudden infant death syndrome)
ECG needs wires, papers and HR
patients in hospitals needs to be wired and are tho limited in their movements
elderly people want to stay and live at home as long as it is possible but
cannot due to lack of necessary monitoring
Solution (product or service)
Smedo provides maximum freedom and comfort for personnel and patients
and delivers accurate vital data with zero disruption.
No wires, no restrictions, no effort. Smedo supervises defined areas and monitors the biometrics.
Acoustic or digital alarms as well as insightful reports can be triggered when and where needed.
manufactors of known baby monitoring systems with cameras
Sensors for assisted living (fall detection, alert buttons etc.)
Advantages or differentiators
For baby monitoring: We can track vital signs without cabling, giving the safety to parents that they are able to act in emergency cases
for ECG: Supplying a highly cost-effective, contactless cable-free ECG system to monitor vital signs 24/7 without HR interacting
Assisted living: Continuos tracking of vital signs can predict heart attacks and even epileptic attacks by pre-measuring them up to 30 minutes before they even happen. Adding fall detection and alert function without wearing any device.
For Baby Monitoring system (first go-to-market solution):
Fully calculated retail price is targeted at below €200,- per device.
Revenue for first test batch (5.000pcs) is €750k at batch costs of €350k (calculated conservatively)
medical cerification is at maximum of €500k (all contacts been made)
we follow a revenue modell through device sales in addition with a software package (monthly fee/sub)
Money will be spent on
€ 500k medical ISO approval (14 months)
€ 300k sensor & software finalization
for baby monitoring (6 months)
€ 450k production preparation (6 months)
€ 350k 1. batch manufacturing, 5.000 pcs
local authorities may delay permission for frequency usage in some target countries
Development may be delayed due to lack of investment. Entrance into market may be delayed so other developing companies may be the first to market then.
Incubation/Acceleration programs accomplishment
Won the competition and other awards
just started pitching, not heading to win awards at pitching events usually